Novartis looks to settle doc-bribery suit; CEO shares update on Zolgensma coverage
The Swiss drugmaker, which reported an otherwise upbeat second quarter, allocated a substantial reserve to settle bribery charges stemming from the suit.
Pharma
AbbVie to buy Allergan as it prepares for a post-Humira world
Allergan comes with a $63 billion price tag.
Biotech Alkermes rebuilds public affairs team
Jeff Winton, who joined Alkermes last year as SVP of public affairs, was tasked with building out the company’s communications function.
Pfizer takes to Twitter to refute ‘Washington Post’ story
The drugmaker said that its decision not to pursue clinical trials on Alzheimer’s for Enbrel was based on science, not financial predictions.
Sanofi names former Novartis executive as CEO
Paul Hudson will replace the retiring Olivier Brandicourt in September.
Ogilvy expands work for Pfizer
The WPP agency added a vaccine awaiting regulatory approval, Centrum and work in emerging markets to its responsibilities for the pharmaceutical company.
MM&M Transforming Healthcare Conference connects marketers with emerging trends
The conference, May 8 in NYC, convenes one of the most diverse, forward-looking faculty for a single day spent exploring healthcare’s cutting edge.
The voices behind pharma DTC ads bring art to science
Big words and warnings. Not much time. The voices behind pharma ads bring art to science.
MM&M reveals Healthcare Transformers and Innovation Catalysts of 2019
The 50 inductees will be celebrated at an awards reception in New York City on the night of May 7.
Immersive health technology has its coming-out party at CES 2019
The Consumer Electronics Show has become an early-year trend barometer for health tech, and this year was no different as immersive tech took center stage at the annual Las Vegas event.
